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Abstract 
As a major infectious disease in chickens, Newcastle disease causes considerable economic losses in 
the poultry industry, especially in developing countries where there is limited access to effective 
vaccination. Therefore, enhancing resistance to the virus in commercial chickens through breeding is a 
promising way to promote poultry production. In this study, we investigated gene expression changes at 2 
and 6 dpi after infection at day21 with a lentogenic Newcastle disease virus in a commercial egg-laying 
chicken hybrid using RNA sequencing analysis. By comparing NDV challenged and nonchallenged groups, 
526 differentially expressed genes (DEGs) (FDR < 0.05) were identified at 2 dpi, and only 36 at 6 dpi. For 
the DEGs at 2 dpi, IPA analysis predicted inhibition of multiple signaling pathways in response to NDV that 
regulate immune cell development and activity, neurogenesis and angiogenesis. Upregulation of 
Interferon Induced Protein with Tetratricopeptide Repeats 5 (IFIT5) in response to NDV was consistent 
between the current and most previous studies. Sprouty RTK Signaling Antagonist 1 (SPRY1), a DEG in the 
current study is located in a significant QTL associated with virus load at 6 dpi in the same population. 
These identified pathways and DEGs provide potential targets to further study breeding strategy to 
enhance NDV resistance in chickens. 
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Abstract: As a major infectious disease in chickens, Newcastle disease causes considerable economic 
losses in the poultry industry, especially in developing countries where there is limited access to 
effective vaccination. Therefore, enhancing resistance to the virus in commercial chickens through 
breeding is a promising way to promote poultry production. In this study, we investigated gene 
expression changes at 2 and 6 dpi after infection at day21 with a lentogenic Newcastle disease virus 
in a commercial egg-laying chicken hybrid using RNA sequencing analysis. By comparing NDV 
challenged and nonchallenged groups, 526 differentially expressed genes (DEGs) (FDR < 0.05) were 
identified at 2 dpi, and only 36 at 6 dpi. For the DEGs at 2 dpi, IPA analysis predicted inhibition of 
multiple signaling pathways in response to NDV that regulate immune cell development and 
activity, neurogenesis and angiogenesis. Upregulation of Interferon Induced Protein with 
Tetratricopeptide Repeats 5 (IFIT5) in response to NDV was consistent between the current and most 
previous studies. Sprouty RTK Signaling Antagonist 1 (SPRY1), a DEG in the current study is located 
in a significant QTL associated with virus load at 6 dpi in the same population. These identified 
pathways and DEGs provide potential targets to further study breeding strategy to enhance NDV 
resistance in chickens. 
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1. Introduction 
As one of the most devastating avian diseases with worldwide distribution, Newcastle disease 
has caused significant economic losses in the global poultry industry.  As a negative-sense and 
single-stranded RNA virus, natural evolution of the Newcastle disease virus (NDV) has resulted in a 
great diversity of strains with varied virulence, from lentogenic and mesogenic to velogenic [1]. 
Certain velogenic strains can cause up to 100% mortality in a chicken flock, and sometimes even 
vaccinated chickens are not adequately protected. In many low-income countries around the world, 
backyard chicken flocks are not provided adequate vaccination and biosecurity [2]. In these countries, 
chickens play a vital role in supporting people’s livelihoods as an important protein and nutrition 
source, and poultry raising also plays a critical role in women’s empowerment, with women 
primarily responsible for decision-making in regards to household chicken production [3]. In 
addition, ND outbreaks occur in commercial poultry operations in these NDV endemic regions as a 
result of improper vaccination programs and challenges associated with maintaining a vaccine cold 
chain required to administer potent and effective vaccines to flocks. Therefore, improving host 
resistance to NDV through genetic selection and breeding is a promising complementary strategy to 
improve poultry production and livelihoods.   
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The use of genetic selection to improve poultry health is feasible because of the apparent genetic 
control of the immune response to NDV, as manifested in different responses to NDV across different 
chicken lines [4-6]. Previously, we have shown moderate to high heritability of NDV response traits, 
including viral load at 2 and 6 days post inoculation (dpi) and antibody titer pre-challenge and at 10 
dpi in a commercial layer chicken hybrid [7]. In addition, through a genome-wide association study 
(GWAS), we have identified major single nucleotide polymorphisms (SNPs) with over 20% genome-
wide significance for each of these traits after Bonferroni correction [7]. However, it is still unclear if 
and how these SNPs affect these traits by regulating gene expression. Previous gene expression 
studies with inbred chicken lines that have distinct responses to NDV [4,8-12] have contributed to 
understanding gene regulation of Newcastle disease resistance, but these studies did not reflect 
commercial settings in two aspects. First, each chicken line had a quite uniform genetic makeup, 
which rarely exists in commercial production. Second, the parents of these chicks did not receive 
NDV vaccination, so there were no maternal antibodies against NDV in these chickens. Therefore, 
we investigated gene expression through RNA sequencing analysis in commercial brown layer 
chickens. Our objectives were to generate a clearer picture of the transcriptomic response to NDV in 
commercial chickens and to identify critical genes that regulate resistance to NDV by combining the 
current RNA-seq and prior GWAS results. The important genes and pathways identified in this study 
represent a further step toward a selective breeding program for enhancing Newcastle disease 
resistance in chickens.  
2. Materials and Methods  
2.1. Animals and Experimental Design 
This study was approved by the Iowa State University Institutional Animal Care and Use 
Committee (IACUC log number 1-13-7490-G). All experiments were performed in accordance with 
the relevant guidelines and regulations. The animal experiment was described previously [7]. Three 
hatches of 200 mixed-sex Hy-Line Brown chicks (N=600) were produced by 16 sires and 145 dams. 
They were separated based on pedigree information to distribute half-sibs into three different ABSL2 
rooms. After being raised with ad libitum access to feed and water until 21 days old, the chickens 
were either treated with the type B1 LaSota lentogenic strain of NDV (200 l of 108 EID50 for each 
chicken, n=540) through nasal and ocular inoculation routes (50 l into each eye and nostril), or 200l 
phosphate-buffered saline (PBS, n=60) through the same routes. Chickens of different genders were 
selected for RNA-seq within each treatment group at 2 and 6 dpi (n=4/group/time) and euthanized 
with sodium pentobarbital. Spleen tissues were collected and placed into RNAlater solution (Thermo 
Fisher Scientific, Waltham, MA) for short-term storage and transferred to a -80°C freezer.  
2.2. Total RNA Isolation 
RNA samples were isolated from spleens using Ambion RNAqueous Total RNA Isolation Kit 
(Thermo Fisher Scientific) following the manufacturer’s protocol. Proper quantity and high quality 
(RNA integrity number > 8) of the RNA samples were ensured through assessment by a NanoDrop 
ND-1000 UV-vis spectrophotometer (Thermo Fisher Scientific) and based on the RNA 6000 Nano kit 
in the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA), respectively.  
2.3. cDNA Library Construction and Sequencing 
The transcriptome library of each sample was constructed with 0.5 µg total RNA using the 
Illumina TruSeq RNA sample preparation kit (Illumina Inc., San Diego, CA) following the low 
sample protocol in the TruSeq RNA sample preparation v2 guide (Part #15026495, March 2014). The 
cDNA in each library was assayed for proper length by running the DNA 1000 assay on the Agilent 
2100 Bioanalyzer. Libraries from 2 and 6 dpi were independently constructed and sequenced at 
different times. Two libraries randomly selected from each treatment group were multiplexed and 
pooled into one lane for sequencing, and the other 2 libraries were similarly placed in the other lane, 
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yielding 2 lanes for each time point. Sequences of 100-bp single-end reads were obtained using the 
HiSeq 2500 Sequencing System (Illumina) at the Iowa State University DNA facility.  
2.4. Sequence Reads Quality Control, Mapping and Counting  
After quality assessment of raw reads using FastQC (version 0.10.1), adapter sequences and 
sequences of low quality (Sanger base quality < 20) were trimmed using the FASTX-Toolkit in 
CyVerse (https://de.cyverse.org/de). The filtered reads of each sample were then aligned to the Gallus 
gallus Galgal 6.0 reference genome (assembly GCA_000002315.5) from Ensembl using TopHat2 
(version 2.1.1) with default parameters. The mapped reads were subsequently counted using HTSeq 
(version 0.6.1), using default parameters and the Gallus gallus Galgal6.0 GTF file from Ensembl.  
2.5. Differential Expression, Pathway, and Co-expression Analyses 
Because the library construction and sequencing steps were done separately for each time point, 
the differential expression analyses for the NDV challenged vs. Nonchallenged contrast were 
performed separately at 2 dpi and 6 dpi using the EdgeR software (version 3.12.1) in R (version 3.2.3). 
The trimmed mean of M-value (TMM) method was used to normalize read counts. A generalized 
linear model (GLM) based on a negative binomial distribution was fitted with the main effect of 
treatment. The Benjamini-Hochberg method was used to control the false discovery rate (FDR). 
Principle component analysis (PCA) plots were generated for each time point by the ggbiplot 
program in R. Differentially expressed genes (DEGs) with FDR < 0.05 were included in the Ingenuity 
Pathway Analysis software (IPA, Qiagen, Redwood City, CA), and pathways or functions with |z-
score|>2 were considered to be activated or inhibited.  
2.6. Fluidigm Biomark assay of gene expression 
 To validate RNA-seq results, the Biomark Dynamic assay (Fluidigm, South San Francisco, CA) 
was used to measure gene expression in the same 16 RNA samples as used in the RNA-seq study. 
Based on their log2FC in RNA-seq analysis, we selected 40 genes that covered the full range of log2FC 
in the comparisons between two treatments. In addition, the functional importance of each gene in 
immune defense was considered in the selection of genes. Primers for these genes were previously 
published [8]. The geometric means of Ct values of 3 housekeeping genes [glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), actin beta (ACTB), and hypoxanthine 
phosphoribosyltransferase 1 (HPRT1)] were used for normalization. For each sample, cDNA was 
prepared from 50 ng of RNA using Reverse Transcription Master Mix and preamplified at 12 cycles 
using Preamp Master Mix (Fluidigm), according to the manufacturer’s protocols. Gene expression 
detection in each sample was performed in duplicate using the Fluidigm 48.48 integrated fluidic 
circuit (IFC). Two IFCs were run in the BioMark HD (Fluidigm) Real-Time PCR system for the 2 dpi 
and 6 dpi samples, and data were analyzed using the Fluidigm Real-Time PCR Analysis software. 
Replicates of the same sample that showed a shifted peak in melting curves were removed from 
further analysis. Gene expression was compared between treatments using the 2(-Ct) method in 
Excel, and the pairwise correlation and linear regression between the Log2FC results from the 
Biomark assay and from RNA-seq were calculated using the JMP Pro 12.0.1 software. 
2.7. Data availability statement 
The raw sequencing data generated and analyzed in the current study are available in 
ArrayExpress repository in EMBL-EBI (http://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-
8350/) with accession number E-MTAB-8350.  
3. Results 
3.1. Gene expression changes induced by NDV 
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Millions of 100-bp single-end reads were obtained for each sample from sequencing of libraries 
constructed with RNA samples from spleen. Although there was large variation in the number of 
raw reads among samples after filtering (from 10,383,866 to 16,783,037), similar percentages of reads 
of each sample were mapped to the Gallus gallus Galgal 6.0 reference genome in the Ensembl database 
(around 90%). On average, expression of 17,255 genes was detected in each sample, accounting for 
71% of the 24,356 annotated genes in the reference genome (Supplementary Table S1). The Log2 fold 
change (log2FC) of 40 selected genes in different treatment comparisons showed very high 
consistency between expression data obtained by Fluidigm Biomark qPCR and RNA-seq (correlation 
coefficient: r=0.91), validating the differential expression identified by RNA-seq (Figure 1). 
 
Figure 1. Gene expression analysis by Fluidigm Biomark assay of log2 fold change (Log2FC) of 
selected genes that were significant for different contrasts in RNA-seq analysis. Contrasts between 
treatments at different time points are marked in different colors and each combination is labeled as 
Time_Treatment (dpi: day post infection; NDV: NDV-challenged, NC: Non-challenged). Pearson 
correlation coefficient is labeled as “r”. Log2FC in Biomark assay equals −ΔΔCt for each 
comparison. Average expression of three housekeeping genes, GAPDH, ACTB and HPRT1, was used 
for normalization of Ct values. 
The PCA plot shows that samples at 2 dpi separated well between the NDV-challenged and non-
challenged groups along principal component 1 (PC1), which explained 28.9% of the variation in 
RNA-seq data among the samples (Figure 2A). Samples at 6 dpi clustered the best along PC2 and 
PC3, but there is still one NDV-challenged sample intermingled with non-challenged group (Figure 
2B). 
Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 4 August 2020                   doi:10.20944/preprints202008.0103.v1
 
 
Figure 2. Principal component analysis (PCA) plots generated with ggbiplot in R showing variation 
and separation of samples between different treatments. (A) PCA plot for samples at 2 days post 
inoculation (dpi). (B) PCA plot for samples at 6 dpi. Sample in different treatments are separated by 
a line. Different treatments are represented in different colors: NDV-challenged (red), non-challenged 
(blue). 
The PCA results also agree with the difference in numbers of DEGs for the NDV-challenged vs. 
non-challenged group between 2 dpi and 6 dpi. At FDR < 0.05, expression of 526 genes was 
significantly changed by NDV treatment at 2 dpi when compared to the non-challenged group. 
Among these DEGs, 84% of them were downregulated by NDV. At 6 dpi, NDV treatment only 
induced differential expression of 36 genes (Figure 3A). Five DEGs were shared between the two time 
points (Figure 2B), which were all downregulated by NDV challenge (Figure 3B). These genes are 
integrin alpha-8 (ITGA8), follicle stimulating hormone receptor (FSHR), thrombospondin 1(THBS1), 
transmembrane protein 47 (TMEM47), Rho GTPase activating protein 20 (ARHGAP20) (Table 1). 
However, the fold change of these genes in response to NDV challenge was not large. Instead, 
Apolipoprotein L Domain Containing 1 (APOLD1), chemokine CCLI7, and Nuclear Receptor 
Subfamily 4 Group A Member 1 (NR4A1) were the top down-regulated genes based on fold change 
(LFC < -3), while neurturin (NRTN) was the top up-regulated gene (LFC>3) at 2 dpi.  
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Figure 3. Number of significant differentially expressed genes (DEGs) for NDV-challenged vs non-
challenged birds at false discovery rate < 0.05. (A) Histogram showing the number of DEGs at 2 and 
6 days post inoculation (dpi), and their distribution. Upregulated and downregulated DEGs are 
represented in red and blue color. DEGs within different ranges of Log2 fold change are represented 
in different brightness of the color. (B) Venn diagram showing the number of overlapping DEGs at 2 
and 6 dpi. 
Table 1. Shared DEGs (p<0.05) for NDV-infected vs. Non-infected at 2 and 6 days post inoculation 
Ensembl ID Gene name 2 dpi 6 dpi 
Log2FC FDR Log2FC FDR 
ENSGALG00000008747 ITGA8 -0.36 0.04896 -0.41 0.04412 
ENSGALG00000009100 FSHR -0.36 0.04813 -0.45 0.04412 
ENSGALG00000009626 THBS1 -0.67 0.01366 -0.42 0.03912 
ENSGALG00000027198 TMEM47 -0.43 0.01800 -0.52 0.00341 
ENSGALG00000036566 ARHGAP20 -0.41 0.00242 -0.67 0.00002 
Note: Log2FC represents log2 fold change. FDR means false discovery rate. 
3.2. Ingenuity pathway analysis of differentially expressed genes 
Ingenuity pathway analysis showed significant inhibition (p < 0.05, z-score < -2) of 52 pathways 
following NDV challenge at 2 dpi, of which the top pathways (z-score < -3) are listed in Table 2. 
Among these pathways, IL-15 production, Tec Kinase signaling, IL-8 signaling are involved in 
immune response, while the other pathways are mainly related to cell adhesion, signaling and 
movement, and neurogenesis and neuropathogenesis (Table 2). Downregulated genes in response to 
NDV were involved in several pathways, like phosphoinositide-3-kinase regulatory subunit 6 
(PIK3R6), SRC proto-oncogene, non-receptor tyrosine kinase (SRC), Fos proto-oncogene, AP-1 
transcription factor subunit (FOS), Integrin Subunit Alpha 3 (ITGA3) and hemopoietic cell kinase 
(HCK) are involved in several pathways.  
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Table 2. Top significant pathways (p < 0.05) predicted by IPAwith differentially expressed genes (DEGs) for the NDV-challenged vs. Non-challenged comparison. 1 
Time Pathways Top DEGs contributing to prediction Ratio z-score 
2 dpi 
 
IL-15 production EPH(A2/A5/B1), ROR1, MATK, SRC, DDR2, FES, HCK, AATK  15/121 -3.357 
Signaling by Rho family GTPases FOS, ARHGEF(11/16/17), ACTA1, ITGA3, JUN, LIMK1, PIK3R6  17/244 -3.153 
GNRH signaling HBEGF, FOS, EGR1, MAP3K(6/14), CAMK2B, CACNA2D2, SRC  14/173 -3.317 
Synaptogenesis signaling pathway EPH(A2/A5/B1), GRIN3B, CAMK2B, THBS1, SRC, HCK, PIK3R6 19/312 -4.000 
  Integrin signaling ACT(A1/N4), BCAR1, ITGA(3/8), SRC, VCL, MPRIP, RHOB, PIK3R6 15/213 -3.606 
Reelin signaling in neurons  GRIN3B, ARHGEF(11/16), ITGA3, CAMK2B, SRC, HCK, PIK3R6  10/129 -3.162 
GP6 signaling pathway LAM(B2/A5), COL(5A1/6A3/24A1), PIK3R6 9/119 -3.000 
Tec kinase signaling FOS, ACTA1, ITGA3, TNFRSF25, SRC, HCK, RHOB, FGR, PIK3R6 9/164 -3.000 
Adrenomedullin signaling pathway FOS, IL1RN, PLCD3, KCNH2, MATK, NPR2, ITPR3, PIK3R6 10/197 -3.000 
IL-8 signaling HBEGF, FOS, SRC, JUN, RHOB, LIMK1, PLD1, FLT4, PIK3R6 9/200 -3.000 
6 dpi Hematopoiesis from multipotent stem cells KITLG 1/12 - 
Granulocyte adhesion and diapedesis HRH1, CCL21 2/180 - 
Chondrotin sulfate degradation HYAL2 1/16 - 
Agranulocyte adhesion and diapedesis HRH1, CCL21 2/193 - 
Dermatan sulfate degradation HYAL2 1/17 - 
G-Protein coupled receptor signaling  FSHR, HRH1 2/272 - 
Inhibition of angiogenesis by TSP1 THBS1 1/34 - 
Note: Bold italic and italic text respectively indicates higher and lower expression of differentially expressed genes (DEGs) in NDV-challenged chickens compared to non-challenged group. Genes are ranked ascendingly based on their fold change from left to right. Genes within the same family 2 
are labeled with the member or subunit names in the brackets. Ratio = (number of DEGs in a pathways)/(Total number of genes in the pathway).  3 
At 6 dpi, no significant pathway was predicted with |z-score| > 2 based change of gene expression, but some pathways were significantly enriched (p < 0.05) 4 
by DEGs (Table 3). Among these pathways, Granulocyte adhesion and diapedesis, Agranulocyte adhesion and diapedesis, Chondrotin sulfate degradation and G-5 
Protein coupled receptor signaling pathways regulate activation of inflammatory response.  The DEGs in these pathways were Histamine receptor H1 (HRH1), 6 
KIT ligand (KITLG), Hyaluronidase 2 (HYAL2), C-C motif chemokine ligand 21 (CCL21), and THBS1 (Table 2). These genes all regulate phagocyte activation, as 7 
shown in Table 3.  8 
 9 
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Table 3. Top disease and functions (p < 0.01) predicted by IPA for NDV-infected vs. Non-infected comparison. 10 
Time Disease and Biofunctions Top DEGs contributing to prediction z-score No. 
2 dpi 
 
Organismal death STAR, NR4A3, KLF4, SIK1, HBEGF, CCN1, ADAMTS4, FOS, IL1RN, DUSP1 9.770 159 
Necrosis NRTN, STAR, NR4A3, KLF4, CCN1, IL1RN, DUSP1, ASTN1, EPHA2, ADAM15 2.841 162 
Viral Infection EGR1, CROCC, MAP3K12, FBLIM1, ARTN, DPP4, FAM167B, BCAR1, BMP1 -5.663 90 
Cell viability NR4A(1/3), HBEGF, CCN(1/2), FOS, DUSP1, CACNB3, WNT5A, EGR1, EPHA2  -5.568 98 
Migration of cells CCL24, PDCH15, HBEGF, CCN1, FOS, ITGA2B, WNT5A, FOSL2, EGR1, EPHA2 -5.554 142 
Vasculogenesis CCL24, NR4A1, HBEGF, ATF3, CCN(1/2), FOS, WNT5A, EGR1, EPHA2, ADAM15 -5.154 66 
Microtubule dynamics ATF3, CCN(1/2), FOS, WNT5A, EGR1, EPHA2, CROCC, METRN, GEM, BCAR1 -4.553 110 
Endocytosis HBEGF, WNT5A, EGR1, PEAR1, FLNA, CSF1, RASA4, THBS1, SRC, HIP1, TGM2 -4.147 43 
Development of neurons CCN1, ADAMTS4, FOS, WNT5A, ARTN, METRN, GEM, ITGA3, NR2F1, EGFL7 -3.640 65 
Leukocyte migration CLL24, HBEGF, CCN(1/2), FOS, ITGA2B, WNT5A, FOSL2, EPHA2, ADAM15 -2.976 69 
Phagocytosis of cells WNT5A, PEAR1, FLNA, RASA4, THBS1, SRC, SCARF1, TGM2, LRP1, HCK, LIMK1 -2.398 26 
6 dpi Proliferation of lymphocytes HRH1, KITLG, ZEB2, THBS1, CCL21 -1.938 5 
Development of neurons FSHR, KITLG, ZEB2, THBS1, CCL21 -1.706 5 
Recruitment of cells HRH1, KITLG, THBS1, CCL21 -1.253 4 
Activation of phagocytes  HRH1, KITLG, THBS1, CCL21, HYAL2 -1.188 5 
Microtubule dynamics KITLG, ZEB2, FSHR, SPATA13, THBS1, ITGA8, CCL21 -1.083 7 
Note: Bold italic and italic text respectively indicates higher and lower expression of differentially expressed genes (DEGs) in NDV-challenged chickens compared to non-challenged group. Genes are ranked ascendingly based on their fold change from left to right. Genes within the same family 11 
are labeled with the member or subunit names in the brackets. No. means number of DEGs related to the disease and biofunction. 12 
Disease and biofunction prediction of IPA suggested decreased cell mobility and viability, decreased immune cell activity, decreased neurogenesis, and 13 
angiogenesis in response to NDV at 2 dpi, which together contribute to increased morbidity and mortality of organism at 2 dpi. By 6 dpi, the NDV challenge seemed 14 
to still have mild inhibitory effects on immune function and the nervous system, which promotes organismal death (Table 3).  15 
3.3. Comparison with previous RNA-seq and GWAS studies 16 
We found 87 genes that were shared between this study and previous reported gene expression changes in response to NDV. Among these genes, 33 (38%) 17 
showed consistent expression changes in response to NDV in spleen of Hy-Line Brown birds and in spleen [8,13,14], Harderian gland [9,12], trachea [4], lung [10] 18 
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or embryo [11] of Fayoumi or Leghorn chickens (Table 4). Notably, interferon induced protein with 
tetratricopeptide repeats 5 (IFIT5) showed significant upregulation in response to NDV in the spleen 
of all three chicken lines. 
Table 4. DEGs with consistent responses in expression to NDV in the current and previous studies.  
Gene name Time LFC  Consistent response in other NDV studies 
IFIT5 2 dpi 1.27 Spleen of Leghorn at 1 [13], 2 [8,13] and 6 dpi [8], and of Fayoumi at 2 dpi [8] 
CCL19 6 dpi 0.84 Trachea of Fayoumi and Leghorn at 2 dpi [4] 
AICDA 2 dpi 0.80 Trachea of Leghorn at 6 dpi [4] 
SLBP 2 dpi 0.68 Spleen [8] and trachea [4] of Leghorn at 2 dpi 
TRIM24 2 dpi 0.52 Trachea of Leghorn at 6 dpi [4] 
PLCXD1 2 dpi 0.50 Harderian gland of Leghorn at 6 dpi [9] 
SNX10 2 dpi 0.50 Spleen [8] and trachea [4] of Leghorn at 2 dpi 
DRAM1 2 dpi 0.49 Trachea of Fayoumi and Leghorn at 2 dpi [4] 
FGL2 2 dpi 0.44 Trachea of Leghorn at 2 dpi [4] 
ASNS 2 dpi 0.40 Harderian gland of Leghorn at 6 dpi [9] 
PARP12 2 dpi 0.40 Harderian gland at 2 and 6 dpi [9], in spleen at 2 dpi [8] in Leghorn 
SEPT2 2 dpi 0.38 Trachea of Fayoumi at 2 and 6 dpi and Leghorn at 6 dpi [4] 
BFAR 2 dpi 0.37 Trachea of Fayoumi and Leghorn at 2 dpi [4] 
OSTM1 2 dpi 0.34 Trachea of Leghorn at 2 dpi [4] 
ARHGAP15 2 dpi 0.33 Trachea of Fayoumi at 2 dpi and Leghorn at 2 and 6 dpi [4] 
CDC42SE2 2 dpi 0.33 Trachea of Fayoumi at 2 dpi [4] 
P2RY8 2 dpi 0.33 Harderian gland at 6 dpi [9] and trachea at 2 and 6 dpi [4] in Leghorn 
MYH10 2 dpi -0.37 Trachea of Leghorn at 6 dpi [4] 
FSHR 2&6 dpi -0.40 Trachea of Leghorn at 6 dpi [4] 
SEPT11 2 dpi -0.41 Trachea of Leghorn at 6 dpi [4] 
OGN 6 dpi -0.44 Trachea of Leghorn at 6 dpi [4] 
KAZALD1 2 dpi -0.47 Trachea of Leghorn at 6 dpi [4] 
SRSF5 2 dpi -0.50 Trachea of Leghorn at 2 dpi [4] 
P2RX1 2 dpi -0.51 Lung of Fayoumi at 10 dpi [10] 
HPSE2 2 dpi -0.52 Trachea of Leghorn at 2 dpi [4] 
JUN 2 dpi -0.55 Leghorn embryo [11] 
EPHB1 2 dpi -0.57 Trachea of Fayoumi at 2 dpi [4] 
LMOD1 2 dpi -0.65 Lung of Fayoumi at 10 dpi [10] 
ROR1 2 dpi -0.73 Lung of Fayoumi at 2 dpi [10] 
ST3GAL4 2 dpi -0.77 Harderian gland of Leghorn at 6 dp under heat stress [12] 
UROC1 2 dpi -1.01 Harderian gland of Leghorn at 6 dpi [9] 
Note: Bold text indicates consistent direction of expression change induced by NDV treatment in previous studies compared to the expression change observed in the current study.  
 Compared to the previous GWAS study in the population from which the chickens in this study 
were selected, the most significant overlap is the Sprouty RTK signaling antagonist 1 (SPRY1) gene 
in chromosome 4 (Table 5), which was significantly downregulated by NDV at 2 dpi and is located 
within 1Mb downstream of a SNP that was significantly associated with viral load at 6 dpi [7]. In 
addition, the DEGs filamin binding LIM protein 1 (FBLIM1), zinc finger and BTB domain containing 
17 (ZBTB17), EPH receptor A2 (EPHA2) on chromosome 21 are located within 500 kb downstream of 
a SNP that was significantly associated with antibody titer at 10 dpi [7].   
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    Table 5. DEGs near SNPs identified to be associated with NDV disease traits in previous GWAS studies 
Gene name Time LFC  Trait associated with nearby SNPs identified in previous study 
EPHA2 2 dpi -1.30 Antibody titer at 10 dpi in GWAS with the same population [7] 
FBLIM1 2 dpi -1.09 Antibody titer at 10 dpi in GWAS with the same population [7] 
PANX3 2 dpi -0.88 NDV titer at 6 dpi in GWAS with Hy-Line Brown chickens under heat 
stress [15] and Tanzanian chicken ecotypes [16] 
ST3GAL4 2 dpi -0.77 NDV titer at 6 dpi in GWAS with Hy-Line Brown chickens under heat 
stress [15] and Tanzanian chicken ecotypes [16] 
SPRY1 2 dpi -0.69 Viral load at 6 dpi in GWAS with the same population [7] 
CPN2 2 dpi -0.65 Antibody to NDV at 10 dpi in GWAS with Tanzanian chicken ecotypes [16] 
SRSF5 2 dpi -0.50 NDV titer at 2 dpi in GWAS with Tanzanian chicken ecotypes [16] 
ZBTB17 2 dpi -0.33 Antibody titer at 10 dpi in GWAS with the same population [7] 
 
Pannexin 3 (PANX3), serine and arginine rich splicing factor 5 (SRSF5) and ST3 beta-galactoside 
alpha-2,3-sialyltransferase 4 (ST3GAL4) are another three DEGs located within 1 Mb of SNPs 
significantly associated with viral load at 2 or 6 dpi in Hy-Line Brown under heat stress [15] or 
Tanzanian local chickens [16]. In addition, carboxypeptidase N subunit 2 (CPN2) is another DEG in 
this study that is located within 1 Mb of a SNP associated with antibody titer at 10 dpi in Tanzanian 
local chicken ecotypes [16]. Expression of all these genes is inhibited at 2 dpi by NDV challenge (Table 
5). 
Comparison of the pathways identified in this and other gene expression studies that 
investigated response to NDV showed 17 shared significant pathways (Table 6). Interestingly, all 
these pathways are predicted by IPA to be inhibited (z-score < -2) in spleen of Hy-Line Brown 
chickens but activated in lung [10], trachea [4] and Harderian gland [12] of Fayoumi and Leghorn 
chickens, although all chickens were treated by the same lentogenic strain of NDV.  
Table 6.  Pathways found to be significantly inhibited by NDV in the present study (z-score < -2) 
and identified to be activated by NDV in other studies, as predicted by IPA. 
Pathway z-score Activation predicted by IPA in other studies 
Integrin signaling -3.61 Lung of Fayoumi at 10 dpi [10] 
IL-8 signaling -3.00 Lung of Fayoumi at 10 dpi [10] and trachea of Fayoumi 
and Leghorn at 2 dpi [4] 
Tec kinase signaling -3.00 Lung of Fayoumi at 10 dpi [10] and trachea of Fayoumi 
and Leghorn at 2 dpi [4] 
GP6 signaling pathway -3.00 Harderian gland of Leghorn at 6 dpi under heat stress [12] 
B cell receptor signaling -2.83 Trachea of Fayoumi and Leghorn at 2 dpi [4]  
IL-6 signaling -2.83 Trachea of Fayoumi and Leghorn at 2 dpi [4] 
Production of nitric oxide and reactive 
oxygen species in macrophage  
-2.83 Trachea of Fayoumi and Leghorn at 2 dpi [4] 
P2 purigenic receptor signaling 
pathway 
-2.45 Lung of Fayoumi at 10 dpi [10] 
Fc receptor-mediated phagocytosis in 
macrophages and monocytes 
-2.45 Trachea of Fayoumi and Leghorn at 2 dpi [4] 
Thrombin signaling -2.33 Lung of Fayoumi at 10 dpi [10] 
Ephrin receptor signaling -2.24 Lung of Fayoumi at 10 dpi [10] 
Relaxin signaling -2.24 Lung of Fayoumi at 10 dpi [10] 
CD40 signaling -2.24 Trachea of Fayoumi and Leghorn at 2 dpi [4] 
Leukocyte extravasation signaling -2.12 Trachea of Fayoumi and Leghorn at 2, 6 and 10 dpi [4] 
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TNFR1 signaling -2.00 Trachea of Fayoumi and Leghorn at 2 dpi [4] 
TNFR2 signaling -2.00 Trachea of Fayoumi and Leghorn at 2 dpi [4] 
4. Discussion 
Newcastle disease (ND) is a contagious viral disease that involves complex host-virus 
interactions in the immune, nervous and respiratory systems. Chickens infected with NDV show 
respiratory signs such as gasping and coughing; nervous signs such as tremors, paralyzed wings and 
legs, and twisted neck; swelling in the eyes and neck; watery diarrhea; and reduced egg and meat 
production. ND can cause damage to haematopoietic [17], lymphoid [18], vascular and neural cells 
[19]. NDV can infect and lead to apoptosis of lymphocytes and macrophages, and deactivation of 
heterophils [20]. Although the virus used in this study is a lentogenic, mildly virulent strain, the 
splenic gene expression regulation predicted some corresponding changes toward illness, including 
inhibition of immune cell migration, neuron development, and vasculogenesis.  
Among the top 10 pathways (z-score < -3) altered by NDV at 2 dpi, the decreased expression of 
PIK3R6 contributes to inhibition of eight pathways, because phosphoinositide 3-kinases (PI3K) has 
an extensive role in cell survival, migration, growth and differentiation [21]. PI3K which contains 
PIK3R6, is a kinase in leukocytes play an important role in survival and migration of immune cells 
and their function and proliferation [22]. Inhibition of PI3K activation has been proven to promote 
cell apoptosis during early stage NDV infection [23]. Therefore, the downregulation of 3-
phosphoinositide biosynthesis pathways may suppress immune cell function and development.  
The immunosuppressive effect of the NDV vaccine has also manifested in downregulation of 
some immune pathways. IL-15 production mediates development, homeostasis and anti-viral 
response of NK cells and CD8 T cells [24]. Tec kinase signaling pathway is also required for 
differentiation and development of CD4+ [25] and CD8+ T cell [26], and CD8+ T cell activation in 
response to viral infection [27].  IL-8 signaling mainly regulates chemotaxis and activation of 
neutrophils during infectious disease [28]. Therefore, inhibition of these pathways could lead to a 
reduced immune response.  
The pathway analysis also pointed out some pathways related to the repair of damage to 
vascular cells and neural cells which is common in ND pathology. Adrenomedullin signaling is a 
significant pathway regulating endothelial cell apoptosis, angiogenesis and vascular permeability 
[29]. GP6 signaling is an important pathway that protects vascular integrity and prevents bleeding 
by recruiting platelets to neutrophil-induced vascular breach during inflammatory response [30]. 
Inhibition of these pathways may compromise the functional integrity of blood vessels. The 
gonadotropin-releasing hormone (GNRH) is mainly secreted by central nervous system, and GNRH 
signaling is vital for both central and peripheral reproductive regulation [31]. Synaptogenesis 
signaling pathway regulates formation of synapses between neurons in nervous system [32]. Reelin 
signaling in neurons is also very important for neuronal migration and aggregation as well as synapse 
function [33]. Therefore, the inhibition of these three pathways may be related to nervous damage 
caused by NDV.  
Most genes among the 526 DEGs at 2 dpi showed less than 2 times decrease in their expression, 
indicating that these predicted negative responses are moderate even if they are statistically 
significant. There was no mortality in the chickens in this study, and the response was alleviated 
greatly by 6 dpi. The consistent downregulation of Rho GTPase activating gene ARHGAP20, integrin 
gene ITGA8, FSHR and THBS1 (Table 1) between 2 and 6 dpi suggests constant inhibition of 
microtubule dynamics (Table 3). 
The inhibition of pathways that regulate cellular actin and microtubule dynamics, such as 
signaling by Rho family GTPases and integrin signaling, may block NDV entry into host cells through 
fusion of viral envelope with the plasma membrane of target cells or fusion of infected cells with 
adjacent cell membrane [34]. Inhibition of Rho family GTPases pathway has been shown to inhibit 
the cell-cell fusion induced by glycoprotein of respiratory syncytial virus [35].  
The small proportion of shared DEGs between the current study and previous studies, as well 
as the opposite regulation of 17 shared significant pathways predicted by IPA suggest quite different 
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response to NDV in different tissues or chicken lines. This is consistent with the previous reports 
about tissue-specific immune response [36] and distinct immune gene expression between different 
chicken breeds [37]. Maternally transferred antibody may also be a contributing factor to gene 
expression differences among studies. Because the Hy-Line Brown chickens in this study are 
commercial chickens whose dams had received 5 immunizations for NDV before production of the 
chicks, they had detectable circulating maternal antibody at the time of NDV challenge [7]. But 
Fayoumi and Leghorn chickens in other studies [4,9,10,12] did not have detectable maternal antibody 
at the time of experiment. It has been shown that maternal antibody has a blocking effect on the 
immune response to NDV vaccination in chickens [38,39] and kittiwakes [40]. Although the trans-
generation transfer of antibody is believed to protect the neonates during a vulnerable period and 
save the energy of costly innate immune response for growth and development, it could suppress 
humoral immunity by binding and hiding antigen epitope from neonatal B-cells [41]. Therefore, the 
difference of maternal antibody may also contribute to the differential expression profiles among 
these studies.  
On the other hand, those genes showing consistent expression regulation despite many varied 
experimental factors may play a universal role in immune response to NDV. One of the most 
significant of those genes is IFIT5 (Table 4). As an interferon-stimulated gene, IFIT5 has been shown 
to be critical for innate immune defense against virus [42] by recognizing and inhibiting translation 
of viral RNA bearing a 5′-triphosphate [43], and positively regulating of nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-B) signaling [44].  Transgenic chickens with overexpression 
of IFIT5 showed significant enhanced resistance to velogenic NDV, with remarkable reduction of 
chickens with clinical signs when challenged with a clinical dose (10E5 EID50) and a 4-day delay of 
death when challenged with lethal dose (10E6 EID50) [45].   
The finding of SPRY1 as a DEG induced by NDV and a positional candidate gene associated 
with NDV viral load in GWAS in the same animal experiment indicates its significance in the 
regulation of response to NDV. SPRY1, as a modulator of fibroblast growth factor, epidermal growth 
factor signaling [46] and receptor tyrosine kinase signaling pathways [47], has a ubiquitin role in 
tissue development and critical role for proper function. It is an important regulator for angiogenesis 
[48],  vascular smooth muscle cell differentiation [49], hematopoiesis [50], T cell proliferation [51], 
splenic erythropoiesis [52], uretic [53] and mammary [46] epithelial branching morphogenesis. 
Ablation of SPRY1 has been shown to increase splenic erythropoiesis [52], as well as survival and 
activity of CD4+ and CD8+ T cells [51,54]. Therefore, the downregulation of SPRY1 may be a positive 
response against the viral infection. FBLIM1, ZBTB17 and EPHA2 are DEGs in this study and 
positional candidate genes associated with antibody titer in the same animal experiment. Mutation 
of ZBTB17 has been reported to block early intrathymic T cell development [55]. EPHA2 is an 
important gene regulating neurogenesis [56], angiogenesis [57], integrin-mediated cell adhesion and 
cell migration [58]. Therefore, they may have important function in immune defense and tissue repair 
during NDV challenge. CPN2, SRSF5, ST3GAL4, PANX3 are DEGs in vicinity of SNPs associated with 
antibody titer or viral load in other NDV studies under artificial [15]or natural [16]heat stress, 
suggesting the necessity of scrutiny in their functions in protection of immune system against 
suppression of heat stress.  
In conclusion, we observed extensive negative regulation of gene expression in response to NDV 
in the spleen of Hy-Line Brown chickens, although this seems mitigated from 2 dpi to 6 dpi. The quite 
different gene expression responses to NDV vaccine in this study compared to the other previous 
studies may be due to the difference of tissues, chicken population and maternal antibody. Through 
comparison of DEGs in this study with previously identified DEGs and positional candidate genes 
from GWAS, we identified some critical genes that regulate response to NDV in chickens. This is a 
further step toward understanding the molecular regulation of response to NDV challenge and 
identifying the potential key targets to enhance NDV resistance through breeding in poultry.  
Supplementary Materials: The following are available online at www.mdpi.com/xxx/s1, Figure S1: title, Table 
S1: title, Video S1: title.  
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